Group 4: Clinical Trials

17 trials of Group 4, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 3 unknown, 1 active not recruiting, 1 suspended. 5 Not applicable, 3 Phase 2, 2 Phase 1, 2 Phase 4, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Active not recruiting 1, Unknown 1
Phase 23Completed 2, Terminated 1
Phase 12Completed 2
Phase 42Completed 2
Early Phase 11Completed 1
Phase 31Completed 1

Follow Group 4: new trials by email Literature Review of Group 4 trials Research Report on Group 4

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Technical Development of Multi-Parametric Renocerebral MRI
MRI, Group 4 - Aging
SuspendedUniversity of Minnesota1202027-12-012026-10-14
Evaluation of the Effect of Leucocyte Platelet-Rich Fibrin (L-PRF) Technique Applied in Post-extraction Sockets Before Placement of Dental Implants
Allograft and collagen membrane, Allograft and L-PRF membrane, L-PRF - L-PRF, Dental Implants
Not applicableActive not recruitingNational and Kapodistrian University of Athens402022-09-052026-02-04
Frontal Electroencephalography of Neonatal Patients Under Sedation With Opioids and General Anesthesia With Propofol.
Propofol Group 1, Propofol Group 2, Propofol Group 3 - Anesthesia, Surgery
Not applicableCompletedPontificia Universidad Catolica de Chile202021-05-032023-03-07
Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD)
Part 1, Part 2 Group 1, Part 2 group 2 - Anaphylaxis
Phase 1CompletedBausch & Lomb Incorporated432017-03-232019-06-21
Information Recall on Informed Consent to Intravenous Thrombolysis in Patients With Acute Ischaemic Stroke.
Group 1 - Stroke
UnknownCharite University, Berlin, Germany2602016-12-212020-11-13
Vorapaxar on Thrombin Generation and Coagulability
Vorapaxar, Vorapaxar and Aspirin, Vorapaxar and Clopidogrel - Coronary Artery Disease, Peripheral Vascular Disease
Phase 4CompletedInova Health Care Services812016-01-012022-08-18
Research of Intensive Lifestyle Intervention for PCOS Patients With IGT
intensive lifestyle intervention, GLP-1 Receptor Agonists, Metformin - Polycystic Ovary Syndrome
Not applicableCompletedRenJi Hospital402015-04-012022-10-17
Comparison of 3 Different Density Levobupivacaine Solutions + Fentanyl for Spinal Anaesthesia for Caesarean Delivery.
Chirocaine %0.5, Chirocaine Heavy 40, Chirocaine Heavy 60 - Anesthesia
Phase 4CompletedBalikesir University1002014-06-012019-05-20
A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)
iCo-007 350 mcg, iCo-007 700 mcg, iCo-007 350 mcg and Laser - Diabetic Macular Edema
Phase 2TerminatedJohns Hopkins University1852012-02-012017-08-30
The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms
Placebo, Terazosine, Tolterodine - Disorder of Urinary Stent
Phase 2 / Phase 3CompletedUrmia University of Medical Sciences1042012-01-012015-03-02
A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years
Vaccine - Meningococcal Vaccine
Phase 2CompletedPfizer17142011-03-032022-10-27
Bioavailability of Vitamin D Encapsulated in Casein Micelles, Compared to Its Bioavailability in the Milk-fat, or in a Synthetic Emulsifier Currently Used for Supplementation and Enrichment
Group 1, Group 2, group 3 - Healthy Individuals
Not applicableUnknownRambam Health Care Campus1202011-01-012010-12-14
Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment
nutrition /swallowing counseling, G-tube/swallowing intervention, nutrition /swallowing intervention - Head and Neck Cancer, Surgery
WithdrawnUniversity of Alberta2010-10-012016-05-23
The Mental Activity and eXercise Trial for Seniors
Group 1, Group 2, Group 3 - Cognitive Impairment
Not applicableCompletedUniversity of California, San Francisco1262007-08-012012-04-09
Effectiveness of Caudal Epidural Injections in Treatment of Chronic Low Back and Lower Extremity Pain
Caudal epidural injection, Caudal Epidural Injection with generic Celestone, Caudal Epidural Injection with Celestone - Low Back Pain
Early Phase 1CompletedPain Management Center of Paducah2402007-01-012013-08-16
DIagnostics, Fatty Acids and Vitamin D in SCA
Group 1, Group 2, Group 3 - Out-of-Hospital Cardiac Arrest, Ventricular Fibrillation
UnknownHelse Stavanger HF1162007-01-012021-08-11
Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients
group 1, group 2, group 3 - Melanoma
Phase 1CompletedCentre Hospitalier Universitaire Vaudois292003-04-012013-04-22

Conditions studied

Anaphylaxis (1)  ·  Cognitive Dysfunction (1)  ·  Coronary Artery Disease (1)  ·  Death, Sudden, Cardiac (1)  ·  Dementia (1)  ·  Head and Neck Neoplasms (1)  ·  Intervertebral Disc Displacement (1)  ·  Low Back Pain (1)  ·  Melanoma (1)  ·  Motor Activity (1)  ·  Myocardial Infarction (1)  ·  Out-of-Hospital Cardiac Arrest (1)  ·  Peripheral Vascular Diseases (1)  ·  Polycystic Ovary Syndrome (1)  ·  Spinal Stenosis (1)

Sponsors

Balikesir University (1)  ·  Bausch & Lomb Incorporated (1)  ·  Centre Hospitalier Universitaire Vaudois (1)  ·  Charite University, Berlin, Germany (1)  ·  Helse Stavanger HF (1)  ·  Inova Health Care Services (1)  ·  Johns Hopkins University (1)  ·  National and Kapodistrian University of Athens (1)  ·  Pain Management Center of Paducah (1)  ·  Pfizer (1)  ·  Pontificia Universidad Catolica de Chile (1)  ·  Rambam Health Care Campus (1)  ·  RenJi Hospital (1)  ·  University of Alberta (1)  ·  University of California, San Francisco (1)

Countries

United States (5)  ·  Germany (3)  ·  Canada (1)  ·  Chile (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  Greece (1)  ·  Iran (1)  ·  Norway (1)  ·  Poland (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)

Top investigators

Ali Tehranchi, Urologist (1)  ·  Beate Klaus, MD (1)  ·  Brian B. Berger, MD (1)  ·  Catherine A Kubrak, PhD (1)  ·  David Callanan, MD (1)  ·  David M. Brown, MD (1)  ·  Dean Eliott, MD (1)  ·  Deborah E Barnes, PhD, MPH (1)  ·  Dennis M. Marcus, MD (1)  ·  Dennis WT Nilsen, MDd PhD (1)  ·  Diana V. Do, MD (1)  ·  Eugene Lit, MD (1)  ·  Goergios Papastergio, MD (1)  ·  Gregg T. Kokame, MD (1)  ·  Henry L. Hudson, MD (1)

Results publications

PMID 15696196, PMID 21102963, PMID 21234696, PMID 21267039, PMID 21796616, PMID 22828681, PMID 23545598, PMID 26407272, PMID 29930943, PMID 32681472, PMID 34089982, PMID 35164991, PMID 37021170, PMID 40420743

NIH funding

2009 (1), K01AG024069 (1)